FI900863A0 - Analogous process for the preparation of therapeutically useful 3- (tetrahydropyrido-, dihydropyrrolo- and tetrahydropyrazino / 1,2-a / indol-10-yl) pyrrole-2,5-dione derivatives - Google Patents
Analogous process for the preparation of therapeutically useful 3- (tetrahydropyrido-, dihydropyrrolo- and tetrahydropyrazino / 1,2-a / indol-10-yl) pyrrole-2,5-dione derivativesInfo
- Publication number
- FI900863A0 FI900863A0 FI900863A FI900863A FI900863A0 FI 900863 A0 FI900863 A0 FI 900863A0 FI 900863 A FI900863 A FI 900863A FI 900863 A FI900863 A FI 900863A FI 900863 A0 FI900863 A0 FI 900863A0
- Authority
- FI
- Finland
- Prior art keywords
- pyrrole
- tetrahydropyrazino
- dihydropyrrolo
- tetrahydropyrido
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
The pyrrole derivatives of the formula <IMAGE> in which R<1> to R<8>, R, X, Y and m have the meaning given in the description, are therapeutically active substances, in particular for use as substances having antiinflammatory, immunological, oncological, bronchopulmonary and cardiovascular activity or as active substances in the treatment of asthma or AIDS. They are prepared from corresponding furandione derivatives in which X and Y stand for =N-R or O.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8904161 | 1989-02-23 | ||
GB898904161A GB8904161D0 (en) | 1989-02-23 | 1989-02-23 | Substituted pyrroles |
GB898928210A GB8928210D0 (en) | 1989-02-23 | 1989-12-13 | Substituted pyrroles |
GB8928210 | 1989-12-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI900863A0 true FI900863A0 (en) | 1990-02-21 |
FI93447B FI93447B (en) | 1994-12-30 |
FI93447C FI93447C (en) | 1995-04-10 |
Family
ID=26295005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI900863A FI93447C (en) | 1989-02-23 | 1990-02-21 | Analogous process for the preparation of therapeutically useful 3- (tetrahydropyrido, dihydropyrrolo and tetrahydropyrazino [1,2-a] indol-10-yl) pyrrole-2,5-dione derivatives |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0384349B1 (en) |
JP (1) | JPH06102661B2 (en) |
AT (1) | ATE104972T1 (en) |
AU (1) | AU633051B2 (en) |
CA (1) | CA2010636C (en) |
CZ (1) | CZ284587B6 (en) |
DE (1) | DE59005491D1 (en) |
DK (1) | DK0384349T3 (en) |
DZ (1) | DZ1399A1 (en) |
ES (1) | ES2052995T3 (en) |
FI (1) | FI93447C (en) |
HU (1) | HU206351B (en) |
IE (1) | IE64184B1 (en) |
IL (1) | IL93433A (en) |
MC (1) | MC2096A1 (en) |
NO (1) | NO174891C (en) |
NZ (1) | NZ232589A (en) |
PT (1) | PT93246B (en) |
RU (2) | RU2142460C1 (en) |
SK (1) | SK85590A3 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2046801C (en) * | 1990-08-07 | 2002-02-26 | Peter D. Davis | Substituted pyrroles |
US5292747A (en) * | 1990-08-07 | 1994-03-08 | Hoffman-La Roche Inc. | Substituted pyrroles |
DE4128015A1 (en) * | 1991-08-23 | 1993-02-25 | Kali Chemie Pharma Gmbh | 1,7-ANELLIZED 2- (PIPERAZINOALKYL) INDOL DERIVATIVES AND METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
GB9123396D0 (en) * | 1991-11-04 | 1991-12-18 | Hoffmann La Roche | A process for the manufacture of substituted maleimides |
EP0630241A1 (en) * | 1992-03-20 | 1994-12-28 | The Wellcome Foundation Limited | Indole derivatives with antiviral activity |
AU678435B2 (en) * | 1993-05-10 | 1997-05-29 | F. Hoffmann-La Roche Ag | Substituted pyrroles |
US5721230A (en) * | 1993-05-10 | 1998-02-24 | Hoffmann-La Roche Inc. | Substituted pyrroles |
US5405864A (en) * | 1993-10-15 | 1995-04-11 | Syntex (U.S.A.) Inc. | Chemotherapeutic maleimides |
ES2134910T3 (en) * | 1993-12-07 | 1999-10-16 | Lilly Co Eli | SYNTHESIS OF BISINDOLILMALEIMIDAS. |
US5843935A (en) * | 1993-12-07 | 1998-12-01 | Eli Lilly And Company | Protein kinase C inhibitors |
US5541347A (en) * | 1993-12-07 | 1996-07-30 | Eli Lilly And Company | Synthesis of bisindolylmaleimides |
US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
HU219709B (en) * | 1993-12-07 | 2001-06-28 | Eli Lilly And Co. | Condensed indole derivatives of protein kinase c inhibitor activity, process for preparing them and pharmaceutical compositions containing them |
US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
PT817627E (en) | 1993-12-23 | 2005-07-29 | Lilly Co Eli | PROTEIN INHIBITORS CINASE C |
US5481003A (en) * | 1994-06-22 | 1996-01-02 | Eli Lilly And Company | Protein kinase C inhibitors |
US5491242A (en) * | 1994-06-22 | 1996-02-13 | Eli Lilly And Company | Protein kinase C inhibitors |
DE69505470T2 (en) * | 1994-08-04 | 1999-05-12 | F. Hoffmann-La Roche Ag, Basel | Pyrrolocarbazole |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5475110A (en) * | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5591855A (en) * | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5594009A (en) * | 1994-10-14 | 1997-01-14 | Cephalon, Inc. | Fused pyrrolocarbazoles |
DK0797575T3 (en) * | 1994-12-13 | 2004-02-16 | Hoffmann La Roche | Imidazole derivatives as protein kinase inhibitors, especially EGF-R tyrosine kinase |
US5616724A (en) * | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
ATE258050T1 (en) * | 1996-10-31 | 2004-02-15 | Harbor Branch Oceanographic | USE OF NEUROGENIC ANTI-INFLAMMATORY COMPOUNDS AND COMPOSITIONS |
EP1224932A4 (en) * | 1999-08-20 | 2002-10-16 | Sagami Chem Res | Drugs inhibiting cell death |
PL366701A1 (en) | 2000-07-27 | 2005-02-07 | F.Hoffmann-La Roche Ag | 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
MXPA03005140A (en) | 2000-12-08 | 2004-10-15 | Johnson & Johnson | Indazolyl-substituted pyrroline compounds as kinase inhibitors. |
TWI335221B (en) | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
CA2533861A1 (en) | 2003-08-08 | 2005-02-17 | Novartis Ag | Combinations comprising staurosporines |
ES2402298T3 (en) * | 2004-01-19 | 2013-04-30 | Novartis Ag | Indolylmaleimide derivatives as inhibitors of graft rejection treatment or autoimmune diseases |
AU2005313485B2 (en) | 2004-12-08 | 2011-02-03 | Johannes Gutenberg-Universitat Mainz | 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
EP1846406B9 (en) | 2005-02-09 | 2012-01-11 | ArQule, Inc. | Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
KR20080023732A (en) | 2005-07-11 | 2008-03-14 | 노파르티스 아게 | Indolylmaleimide derivatives |
ES2443022T3 (en) * | 2005-08-12 | 2014-02-17 | Merck Frosst Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
EP1980561B1 (en) | 2007-03-30 | 2013-10-09 | Nerviano Medical Sciences S.R.L. | Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors |
CN101801969B (en) | 2007-06-22 | 2014-10-29 | 艾科尔公司 | Indolyl pyrrolidines for the treatment of cancer |
JP2010530885A (en) | 2007-06-22 | 2010-09-16 | アークル インコーポレイテッド | Quinazolinone compounds and methods of use thereof |
EP2170870B1 (en) * | 2007-06-22 | 2014-03-05 | ArQule, Inc. | Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
AU2009295230A1 (en) * | 2008-09-22 | 2010-03-25 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
EP2343291A1 (en) | 2009-12-18 | 2011-07-13 | Johannes Gutenberg-Universität Mainz | 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
US8563567B2 (en) | 2009-12-30 | 2013-10-22 | Arqule, Inc. | Substituted heterocyclic compounds |
EP2474541A1 (en) | 2010-12-23 | 2012-07-11 | Johannes- Gutenberg-Universität Mainz | Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
KR20160003752A (en) * | 2013-04-23 | 2016-01-11 | 라보라토리오스 델 드라. 에스테브.에스.에이. | Pyrazino[1,2-a]indole compounds, their preparation and use in medicaments |
JP2017524739A (en) | 2014-07-17 | 2017-08-31 | アンセルムInserm | Method for treating neuromuscular junction related diseases |
WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
EP3187495A1 (en) | 2015-12-30 | 2017-07-05 | Johannes Gutenberg-Universität Mainz | 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89167A (en) * | 1988-02-10 | 1994-02-27 | Hoffmann La Roche | Substituted pyrroles, their manufacture and pharmaceutical compositions containing them |
EP0350129A1 (en) * | 1988-07-07 | 1990-01-10 | Duphar International Research B.V | New annelated indoleketones with an imidazolylalkyl substituent |
-
1990
- 1990-02-16 MC MC902110A patent/MC2096A1/en unknown
- 1990-02-19 HU HU90846A patent/HU206351B/en not_active IP Right Cessation
- 1990-02-19 IL IL9343390A patent/IL93433A/en not_active IP Right Cessation
- 1990-02-19 NZ NZ232589A patent/NZ232589A/en unknown
- 1990-02-19 DE DE59005491T patent/DE59005491D1/en not_active Expired - Fee Related
- 1990-02-19 AT AT9090103142T patent/ATE104972T1/en not_active IP Right Cessation
- 1990-02-19 ES ES90103142T patent/ES2052995T3/en not_active Expired - Lifetime
- 1990-02-19 DK DK90103142.7T patent/DK0384349T3/en active
- 1990-02-19 EP EP90103142A patent/EP0384349B1/en not_active Expired - Lifetime
- 1990-02-21 FI FI900863A patent/FI93447C/en not_active IP Right Cessation
- 1990-02-21 AU AU50033/90A patent/AU633051B2/en not_active Ceased
- 1990-02-21 DZ DZ900033A patent/DZ1399A1/en active
- 1990-02-22 NO NO900855A patent/NO174891C/en unknown
- 1990-02-22 CA CA002010636A patent/CA2010636C/en not_active Expired - Fee Related
- 1990-02-22 RU RU93033479A patent/RU2142460C1/en active
- 1990-02-22 SK SK855-90A patent/SK85590A3/en unknown
- 1990-02-22 JP JP2042286A patent/JPH06102661B2/en not_active Expired - Fee Related
- 1990-02-22 CZ CS90855A patent/CZ284587B6/en not_active IP Right Cessation
- 1990-02-22 PT PT93246A patent/PT93246B/en not_active IP Right Cessation
- 1990-02-22 IE IE64790A patent/IE64184B1/en not_active IP Right Cessation
- 1990-02-22 RU SU904743198A patent/RU2014332C1/en active
Also Published As
Publication number | Publication date |
---|---|
HU900846D0 (en) | 1990-04-28 |
IL93433A (en) | 1996-11-14 |
DK0384349T3 (en) | 1994-09-05 |
CA2010636A1 (en) | 1990-08-23 |
AU5003390A (en) | 1990-08-30 |
RU2014332C1 (en) | 1994-06-15 |
CA2010636C (en) | 1999-12-14 |
EP0384349A1 (en) | 1990-08-29 |
AU633051B2 (en) | 1993-01-21 |
MC2096A1 (en) | 1991-02-15 |
NO174891C (en) | 1994-07-27 |
DZ1399A1 (en) | 2004-09-13 |
SK278711B6 (en) | 1998-01-14 |
PT93246A (en) | 1990-08-31 |
CZ284587B6 (en) | 1999-01-13 |
NO174891B (en) | 1994-04-18 |
HUT53369A (en) | 1990-10-28 |
FI93447C (en) | 1995-04-10 |
CZ85590A3 (en) | 1998-10-14 |
IL93433A0 (en) | 1990-11-29 |
FI93447B (en) | 1994-12-30 |
IE64184B1 (en) | 1995-07-12 |
SK85590A3 (en) | 1998-01-14 |
NO900855L (en) | 1990-08-24 |
EP0384349B1 (en) | 1994-04-27 |
PT93246B (en) | 1996-01-31 |
ES2052995T3 (en) | 1994-07-16 |
IE900647L (en) | 1990-08-23 |
NZ232589A (en) | 1992-09-25 |
NO900855D0 (en) | 1990-02-22 |
JPH06102661B2 (en) | 1994-12-14 |
HU206351B (en) | 1992-10-28 |
ATE104972T1 (en) | 1994-05-15 |
DE59005491D1 (en) | 1994-06-01 |
JPH02264776A (en) | 1990-10-29 |
RU2142460C1 (en) | 1999-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI900863A0 (en) | Analogous process for the preparation of therapeutically useful 3- (tetrahydropyrido-, dihydropyrrolo- and tetrahydropyrazino / 1,2-a / indol-10-yl) pyrrole-2,5-dione derivatives | |
CA2102179A1 (en) | Quinuclidine derivatives | |
AU5061190A (en) | Novel benzimidazole and azabenzimidazole derivatives, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers | |
RU93033479A (en) | METHOD FOR OBTAINING SUBSTITUTED PYRROLES, METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS | |
AU7535087A (en) | The process for the manufacture of spiro-linked pyrrolidine-2,5-dione derivatives | |
NO873125L (en) | PROCEDURE FOR THE MANUFACTURE OF ANTIBACTERIAL COMPOUNDS. | |
TR200001141T2 (en) | Cyclopentene derivatives useful as motilin receptor antagonists. | |
DE69010257D1 (en) | Process for the preparation of N-substituted maleimides. | |
CA2268399A1 (en) | Anti-neurogenic inflammatory compounds and compositions and methods of use thereof | |
ES2162856T3 (en) | SEROTONINERGIC ERGOLINE DERIVATIVES. | |
AU529996B2 (en) | Synthesis of vincaminic acid derivatives | |
EP0812844A3 (en) | Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof | |
ATE100102T1 (en) | SUBSTITUTED DERIVATIVES OF 20,21DINOREBUNAMENINE, PROCESSES FOR THE MANUFACTURE AND INTERMEDIATE PRODUCTS SO MANUFACTURED, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
NO882959L (en) | PROCEDURE FOR THE PREPARATION OF HIGH-DETERMINATING 3- (3-PYRIDYL) -1H, 3H-PYRROLO (1,2-C) TIAZOL-7-CARBOXYLIC ACID. | |
NO880405D0 (en) | PROCEDURE FOR THE PREPARATION OF 3-PHENYL-7H-TIAZOLO- / 3,2-B // 1,2,4 / -TIAZINE-7-ONER. | |
DE68922596D1 (en) | 3- (3-Ethyl-1,2,4-oxadiazol-5-yl) -1-azabicycloheptane, process for its preparation and pharmaceutical preparations containing it. | |
NO178890C (en) | Analogous Process for the Preparation of Therapeutically Active Pyrrole [2,3-Bone Indole Ketones | |
IE780849L (en) | Thienamycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: F. HOFFMANN - LA ROCHE AG |
|
MA | Patent expired |